Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06140628
Status:
COMPLETED
Last Update Posted:
2023-12-14
First Post:
2023-10-31
Brief Title:
A 28-day Clinical Study on Facial Skin Rejuvenation
Sponsor:
Botanee Group Co Ltd
Organization:
Botanee Group Co Ltd
Study Overview
Official Title:
Clinical Study on 28 Day Continuous Improvement of Post-rejuvenation-treatment Skin With Formulations of A Proprietary Anti-aging Complex Composition
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial aims to learn about the efficacy of MLYAAT-1002 a proprietary anti-aging complex MLYAAT is short for multi-layer anti-ageing technology in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores skin attributes measurement and image analysis
Detailed Description:
The main expectation it aims to answer are
After the 4-week continuous use of the test skin product with MLYAAT-1002 the skin aging problem is significantly improved compared with it of controlled product
After the single use of the test skin product with MLYAAT-1002 the instant skin irritation after the Fotona4D Pro treatment a nonablative fractional laser treatment for facial skin rejuvenation is significantly lower compared with it of controlled product
After the 4-week continuous use of the test skin product with MLYAAT-1002 the skin TEWL transepidermal water loss is significantly recovered from the Fotona4D Pro treatment compared with it of controlled product And the skin TEWL after the 4-week continuous use of test product is improved or not significantly worse than it before the Fotona4D Pro treatment
After the 4-week continuous use of the test skin product with MLYAAT-1002 no skin irritation symptom is worsen compared to it after the Fotona4D Pro treatment
After the 4-week continuous use of the test skin product with MLYAAT-1002 the skin aging problem is significantly improved compared with it of controlled product
After the single use of the test skin product with MLYAAT-1002 the instant skin irritation after the Fotona4D Pro treatment a nonablative fractional laser treatment for facial skin rejuvenation is significantly lower compared with it of controlled product
After the 4-week continuous use of the test skin product with MLYAAT-1002 the skin TEWL transepidermal water loss is significantly recovered from the Fotona4D Pro treatment compared with it of controlled product And the skin TEWL after the 4-week continuous use of test product is improved or not significantly worse than it before the Fotona4D Pro treatment
After the 4-week continuous use of the test skin product with MLYAAT-1002 no skin irritation symptom is worsen compared to it after the Fotona4D Pro treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None